Effect and safety of Dermofural® 0.15% ointment in the treatment of bacterial infection in patients with mild diabetic foot ulcers

Chemical Bioactive Center0 个研究点目标入组 37 人开始时间: 2016年3月11日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

研究类型: Interventional
分配方式: N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment

•1. Patients who meet the established diagnostic criteria.
•2. Patients older than 18 years.
•3. Patients express voluntary by signing the informed consent to participate in research and completing the set exams.

•1. Pregnancy, postpartum or breastfeeding.
•2. History of allergy or hypersensitivity to Dermofural or any of its components.
•3. Patients suffering or concern clinically determined by the physician either decompensated chronic illness.
•4. Patients being treated with immunotherapy or other cancer treatment or who have received in the last three months prior to this study.
•5. Patients with serious psychiatric disorders or mental disability that prevents him expressing their willingness to participate in the study or evaluation difficult.
•6. Patients who are or have been recently involved (1 month) in another study.
•7. Patients with other active infections requiring the use of antibacterial agents during the study.
•8. Patients who have received systemic antibacterial therapy in the 72 hours before the start of the study.
•9. Patients with more than one diabetic foot ulcer.

发起方

Chemical Bioactive Center